202 results on '"Halfmann, Peter J"'
Search Results
2. A compendium of multi-omics data illuminating host responses to lethal human virus infections
3. Characterization of Omicron BA.4.6, XBB, and BQ.1.1 subvariants in hamsters
4. Broad protection against clade 1 sarbecoviruses after a single immunization with cocktail spike-protein-nanoparticle vaccine
5. Defining the risk of SARS-CoV-2 variants on immune protection
6. Characterization of SARS-CoV-2 Omicron BA.2.75 clinical isolates
7. Hypergraph Models of Biological Networks to Identify Genes Critical to Pathogenic Viral Response
8. Transmission and re-infection of Omicron variant XBB.1.5 in hamsters
9. Characterization of SARS-CoV-2 Omicron BA.4 and BA.5 isolates in rodents
10. Characterization and antiviral susceptibility of SARS-CoV-2 Omicron BA.2
11. Characterization of a new SARS-CoV-2 variant that emerged in Brazil
12. mRNA-1273 and Ad26.COV2.S vaccines protect against the B.1.621 variant of SARS-CoV-2
13. SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters
14. An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies
15. Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift
16. Resilience of S309 and AZD7442 monoclonal antibody treatments against infection by SARS-CoV-2 Omicron lineage strains
17. Site of vulnerability on SARS-CoV-2 spike induces broadly protective antibody against antigenically distinct Omicron subvariants
18. Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development
19. Protective Immunity and Persistent Lung Sequelae in Domestic Cats after SARS-CoV-2 Infection
20. Airway surveillance and lung viral control by memory T cells induced by COVID-19 mRNA vaccine
21. Plasma lipidome reveals critical illness and recovery from human Ebola virus disease
22. Hypergraph models of biological networks to identify genes critical to pathogenic viral response
23. Multivalent nanoparticle-based vaccines protect hamsters against SARS-CoV-2 after a single immunization
24. Revealing fine-scale spatiotemporal differences in SARS-CoV-2 introduction and spread
25. Replicative capacity of SARS-CoV-2 omicron variants BA.5 and BQ.1.1 at elevated temperatures
26. Characterization and antiviral susceptibility of SARS-CoV-2 Omicron BA.2
27. Identification of interferon-stimulated genes that attenuate Ebola virus infection
28. Coronavirus Immunotherapeutic Consortium Database
29. Evolution of a globally unique SARS-CoV-2 Spike E484T monoclonal antibody escape mutation in a persistently infected, immunocompromised individual.
30. Reduced airborne transmission of SARS-CoV-2 BA.1 Omicron virus in Syrian hamsters
31. Multivalent S2-based vaccines provide broad protection against SARS-CoV-2 variants of concern and pangolin coronaviruses
32. Evolution of a globally unique SARS-CoV-2 Spike E484T monoclonal antibody escape mutation in a persistently infected, immunocompromised individual
33. Shedding of infectious SARS-CoV-2 despite vaccination
34. Parsing the role of NSP1 in SARS-CoV-2 infection
35. Nasally delivered interferon-λ protects mice against infection by SARS-CoV-2 variants including Omicron
36. Efficacy of vaccination and previous infection against the Omicron BA.1 variant in Syrian hamsters
37. Asymmetric and non-stoichiometric glycoprotein recognition by two distinct antibodies results in broad protection against ebolaviruses
38. Co-administration of Favipiravir and the Remdesivir Metabolite GS-441524 Effectively Reduces SARS-CoV-2 Replication in the Lungs of the Syrian Hamster Model
39. Long-term, infection-acquired immunity against the SARS-CoV-2 Delta variant in a hamster model
40. Pulmonary lesions induced by SARS-CoV-2 infection in domestic cats
41. Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift
42. Cross-Neutralization of Emerging SARS-CoV-2 Variants of Concern by Antibodies Targeting Distinct Epitopes on Spike
43. Highly Efficient SARS-CoV-2 Infection of Human Cardiomyocytes: Spike Protein-Mediated Cell Fusion and Its Inhibition
44. Comparative Sensitivity of Rapid Antigen Tests for the Delta Variant (B.1.617.2) of SARS-CoV-2
45. Antibody-Dependent Enhancement of SARS-CoV-2 Infection Is Mediated by the IgG Receptors FcγRIIA and FcγRIIIA but Does Not Contribute to Aberrant Cytokine Production by Macrophages
46. Potent neutralization of SARS‐CoV‐2 including variants of concern by vaccines presenting the receptor‐binding domain multivalently from nanoscaffolds
47. Additional file 2 of Hypergraph models of biological networks to identify genes critical to pathogenic viral response
48. Additional file 4 of Hypergraph models of biological networks to identify genes critical to pathogenic viral response
49. Additional file 3 of Hypergraph models of biological networks to identify genes critical to pathogenic viral response
50. Pulmonary lesions induced by SARS-CoV-2 infection in domestic cats.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.